000049061 000__ 01667cam\a22004095i\4500
000049061 001__ 49061
000049061 003__ SzGeWIPO
000049061 005__ 20240708150416.0
000049061 006__ m    eo  d        
000049061 007__ cr bn |||m|||a
000049061 008__ 240321s2023\\\\enk\\\\\o\\\\\000\0\eng\d
000049061 0247_ $$a10.1093/grurint/ikad061$$2doi
000049061 035__ $$a(OCoLC)1427545974
000049061 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000049061 041__ $$aeng
000049061 24500 $$aLegal Requirements of Public Financial Incentives to Prescribe Drugs That Do Not Belong to the Same Generic or Similar Biological Groups.
000049061 264_1 $$a[Oxford, England] :$$bOxford University Press (OUP),$$c2023
000049061 300__ $$a1 online resource (pages  971–973)
000049061 336__ $$atext$$2rdacontent
000049061 337__ $$acomputer$$2rdamedia
000049061 338__ $$aonline resource$$bcr$$2rdacarrier
000049061 4901_ $$aGRUR International,$$x2632-8550 ;$$v72, 10, 2023
000049061 520__ $$aCode of Civil Procedure, Art. 150; Benelux Convention on Intellectual Property (Trademarks and Designs), Art. 2.23(3) ‒ Sporttrading Holland B.V., Sport Concept B.V., Ferro Footwear B.V. and Brandustry B.V. v Converse Inc., Kesbo Sport B.V.
000049061 542__ $$fhttps://academic.oup.com/grurint/article/72/3/231/6998505
000049061 588__ $$aCrossref
000049061 590__ $$aPublished online: 31-Aug-23
000049061 650_0 $$aTrademarks$$xLaw and legislation.
000049061 650_0 $$aIntellectual property.
000049061 650_0 $$aTrademarks$$zThe Netherlands.
000049061 650_0 $$aPharmaceutical policy.
000049061 650_0 $$aTrademarks.
000049061 650_0 $$aPatents.
000049061 7731_ $$tGRUR International$$wGRUR
000049061 830_0 $$aGRUR International,$$x2632-8550 ;$$v72, 10, 2023.
000049061 85641 $$uhttps://doi.org/10.1093/grurint/ikad061$$yonline version
000049061 904__ $$aJournal article
000049061 980__ $$aGRUR